AGRX - Agile Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Agile Therapeutics, Inc.

500 College Road East
Suite 310
Princeton, NJ 08540
United States
609 683 1880

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees22

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman, Pres & CEO644.4kN/A1959
Mr. Geoffrey P. GilmoreSr. VP & Chief Admin. Officer478.92kN/A1966
Dr. Paul Korner M.B.A., M.D.Sr. VP & Chief Medical Officer480.4kN/A1966
Mr. Jason ButchPrincipal Financial Officer, VP & Chief Accounting OfficerN/AN/AN/A
Matthew RileyHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Mr. Robert G. Conway M.E.Sr. VP and Chief Corp. Planning & Supply Chain OfficerN/AN/A1958
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.ConsultantN/AN/A1968
Ms. Amy WelshSr. VP & Chief Commercial OfficerN/AN/A1971
Joseph D'UrsoControllerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of June 1, 2023 is 8. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.